Trial Profile
Retrospective study of bedaquiline in multidrug resistant tuberculosis (MDR-TB) patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Sep 2018
Price :
$35
*
At a glance
- Drugs Bedaquiline (Primary)
- Indications Tuberculosis
- Focus Adverse reactions
- 07 Sep 2018 New trial record
- 24 Aug 2018 Results published in the Clinical Infectious Diseases